# Q500 verify round 2: s56, Pediatric fever

Fresh independent review by Preceptor of the whole revised batch, both lenses (clinical truth, and internal consistency and numbers). File reviewed: `src/samps/s56/pediatric-fever.ts` as it stands now. The whole current file is treated as the revision, including the in-place edits an earlier agent made before the writer. Previous verdict: `docs/reviews/q500-verify-s56.md`. Writer report: `docs/reviews/q500-writer-s56-r2.md`. This reviewer did not write, edit or review this batch before and did not edit any SAMP, source or shared file (REVIEW-RULES rule 1). Every fix below goes back to a writer, and the revision needs another fresh review. All items stay `reviewed: false`. This is an AI audit, not clinician verification.

Batch tests run by the reviewer: `SAMP_BATCH=s56 npx vitest run tests/samps.test.ts tests/samp-quality.test.ts tests/citations.test.ts` passed (3 files, 112 tests). The type check shows no s56 errors.

## Verdicts

| SAMP | Verdict | SAMP fields | q1 | q2 | q3 | q4 |
|---|---|---|---|---|---|---|
| pediatric-fever-48 | FAIL | FAIL (alsoTopics) | PASS | PASS | PASS | |
| pediatric-fever-49 | FAIL | PASS | PASS | PASS | FAIL | PASS |
| pediatric-fever-50 | PASS | PASS | PASS | PASS | PASS | |
| pediatric-fever-51 | FAIL | FAIL (alsoTopics) | PASS | PASS | PASS | |
| pediatric-fever-52 | PASS | PASS | PASS | PASS | PASS | |

Totals: 2 of 5 SAMPs pass. 15 of 16 questions pass. One question fails (an explanation fact the case never gives). Two SAMPs fail on one metadata field each (missing `alsoTopics`). Every required fix from the previous review was applied correctly and completely. All three fixes are small and need no change to any key.

## 1. Required fixes from the previous review

| Item | Required fix | What was done | Verdict |
|---|---|---|---|
| 48 stem | Rewrite the examination so it no longer echoes tox-11 and delirium-agitation-06 | Examination rewritten: cries out at shadows, reaches for things that are not there, red hot face and chest with no sweat on scalp or groin, cracked lips, dry tongue, pupils wide and barely reactive, few bowel sounds, dull suprapubic swelling. "Picking", "recognize her mother", "sluggish", "axillae", a pupil size and "bladder is palpable" are gone. Compared word for word with both signed stems. No phrase is shared. 148 words. | Correct and complete |
| 48 q2 | Replace the ECG repeat | Replaced with decontamination, key "No decontamination" (tox KF6). No catalogue key for decontamination in an antihistamine or anticholinergic ingestion. tox-29 q1 ("No gastric emptying or charcoal") is a hydrocarbon aspiration decision with a different reason. The seed oral case overdose-mixed withholds charcoal for a falling level of consciousness in a TCA overdose, again a different decision. | Correct and complete |
| 48 q3 | Replace the physostigmine repeat | Replaced with lumbar puncture once the toxidrome has cleared but fever and confusion persist (infectious-diseases KF5). No catalogue or Q500 key matches this angle. | Correct and complete |
| 48 q4 (passed) | None | Removed by the earlier agent because pediatric-fever-31 q3 keys "Cool mottled limbs, slow refill". I confirmed that key in the catalogue. The removal is right. | Accepted (rule 4) |
| 49 q2 | Remove the PTU give-away, trim, honest tag | Question removed entirely. No pediatric fever key feature fits beta blockade. | Correct and complete |
| 49 q3 | Low to high order, a twist the bank lacks, one bare KF8 item | Rebuilt as q2: a 36 kg 14-year-old given the 12-and-over package dose. Options 160, 320, 480, 650, 1 000 mg, low to high. Recomputed below. | Correct and complete |
| 49 q4 | Honest tag or rebuild | Removed by the earlier agent (pulmonary-edema-25 q3 keys methimazole). Two new questions (q3 CBC, q4 IV antibiotics in agranulocytosis) carry KF1 and KF3. | Correct, but see the new q3 defect below |
| 50 q4 | Replace the second bare dose | Removed by the earlier agent. 50 keeps 3 questions. KF8 is now 49 q2. | Correct and complete |
| 51 q2 | Replace the perfusion repeat | Removed by the earlier agent. New q2 keys lactate (SSC 2026 strong recommendation). | Correct and complete |
| 51 q3 | Replace the ceftriaxone repeat | Ceftriaxone is now a given fact in the q2 update. | Correct and complete |
| 51 q4 | Replace the third perfusion item | New q3 (menu, None keyed): no adjunct once fluid and epinephrine restore circulation (shock KF8). | Correct and complete |
| 52 q2 | Replace the id-03 q1 repeat | Removed. KF1 stays covered (52 q2 menu, 49 q3, 51 q2). The writer's reason (the 2023 guideline names no single risk rule, so no single defensible key) is sound. | Correct and complete |
| 52 q4 | Replace the piperacillin-tazobactam repeat | Now q3: add a second anti-gram-negative agent (gentamicin) when he becomes unstable, per A6b. | Correct and complete |

Key feature coverage after the revision: KF1 3 (49 q3, 51 q2, 52 q2), KF2 1 (51 q1), KF3 2 (49 q4, 52 q3), KF4 1 (52 q1), KF5 1 (49 q1), KF6 1 (48 q1), KF7 3 (50 q1 to q3), KF8 1 (49 q2). Every pediatric fever key feature is covered. Three questions carry other topics' tags: 48 q2 tox KF6, 48 q3 infectious-diseases KF5, 51 q3 shock KF8. Each is honest (see section 3).

Key positions of the 14 single questions, first to fifth: 3, 3, 2, 3, 3. Highest share 21%. Every position is used.

## 2. Required fixes (this review)

| SAMP | Q | Current text | Flaw | Required change | Source | Confidence |
|---|---|---|---|---|---|---|
| pediatric-fever-48 | SAMP field | `...META` with no `alsoTopics`. q2 is tagged tox KF6 and q3 infectious-diseases KF5. | SAMP_SPEC section 13: "`alsoTopics` lists secondary topics." Cross-topic tags are allowed ("Usually the SAMP's own topic"), but the secondary topics must then be listed. Bank practice: 221 of the 239 SAMPs with a cross-topic tag list it in `alsoTopics`. In the Q500 round only s56 and environmental-23 leave it out. | Add `alsoTopics: ["tox", "infectious-diseases"]` to pediatric-fever-48. | SAMP_SPEC section 13. `src/engine/samp.ts` line 106. | High |
| pediatric-fever-51 | SAMP field | `...META` with no `alsoTopics`. q3 is tagged shock KF8. | As above. | Add `alsoTopics: ["shock"]` to pediatric-fever-51. | SAMP_SPEC section 13 | High |
| pediatric-fever-49 | q3 | Explanation: "Fever, sore throat and mouth ulcers weeks after starting methimazole for Graves disease raise concern for agranulocytosis." | The case never names the drug. The update says only "Her specialist starts a daily tablet" (deliberately, to avoid a mock-mode cue). The explanation states as fact a drug the stem and updates never give (SAMP_SPEC section 3 and section 8: every claim traces to the stem or an update). | Keep the update as it is. Reword the opening so the drug is an inference, for example: "The daily tablet her specialist started for Graves disease is an antithyroid drug, and in a child that is methimazole. Fever, sore throat and mouth ulcers weeks after starting it raise concern for agranulocytosis." No change to the key, options or tag. | SAMP_SPEC sections 3 and 8. Ross 2016 (methimazole for children). | Low |

## 3. Whole-batch review, question by question

### pediatric-fever-48 (Hot, restless toddler after a weekend away)

- Stem: PASS. Order, hyphenated age, vitals in the field, weight given, no names. 148 words (limit 150).
- q1 PASS. The rewritten findings (no sweat, cracked lips, dry tongue, wide poorly reactive pupils, few bowel sounds, suprapubic swelling) all appear in the stem and match the explanation. Each distractor reason is true. Heat stroke is rejected on the cool weekend, which the stem gives.
- q2 PASS. Recomputed: 5 x 50 mg = 250 mg, 250 / 15 = 16.7 mg/kg, above the 7.5 mg/kg Scharman threshold for dimenhydrinate under 6 years. The drive ended at 15:00 and she arrived at 21:00, so the ingestion was at least 6 hours earlier. Chyka 2005 abstract read: not routine, may be considered up to 1 hour, contraindicated unless the airway is intact or protected. Every quoted statement is accurate. Tag tox KF6 is honest (decontamination by timing).
  - Writer flag, charcoal timing in anticholinergic ingestion: the key holds. Chyka also says benefit after 1 hour "cannot be excluded", and some toxicologists extend the window for anticholinergics because gastric emptying slows. Here she is at least 6 hours out, the dose is moderate and she is delirious and uncooperative, so oral charcoal is unrealistic and tube charcoal adds aspiration risk for little gain. Every listed alternative is less defensible than none. Physician-level note only.
  - Writer flag, B6 mock-mode cue: the update names dimenhydrinate, which implies the q1 key. The decision needs the dose and timing, so B6 allows it to stay with a flag. The q3 update (moist skin, 4 mm pupils, voiding) and the q3 distractor "Physostigmine IV" also imply q1, but they add nothing once q2's update is visible. Accepted under B6, recorded for the physician.
- q3 PASS. 18:00 to 09:00 is 15 hours. Venkatesan 2013 confirmed (Europe PMC record, PMC3783060). Sweating, normal pupils and voiding mean the peripheral toxidrome has cleared, while fever persists with sweating restored, so the ingestion no longer explains the fever. LP is the single best of the five options. Physostigmine, more midazolam, observation and a urine screen are correctly rejected. Tag infectious-diseases KF5 (include infection in altered mental status) is honest. Uniqueness: LP keys in the catalogues are for HSV, meningitis or febrile seizure workups, not for persistent fever after a cleared toxidrome.
- SAMP field: FAIL, `alsoTopics` (section 2).

### pediatric-fever-49 (Teenager with evening fevers and a racing heart)

- q1 PASS. Unchanged and passed before. Advisory only: "the ATA point scale for thyroid storm" is the Burch-Wartofsky Point Scale reproduced in the ATA guideline. Calling it "the point scale in the ATA guideline" would be more exact. Not a failure.
- q2 PASS. Recomputed against the SickKids sheet, which I downloaded and read (PDF dated 2024): dose range 10 to 15 mg/kg every 4 to 6 hours, at most 5 doses a day, 480 mg (15 mL liquid or 3 x 160 mg tablets) for 32.0 to 44.0 kg, adult dosing only over 44 kg. 36 kg falls in the 32 to 44 kg band, so 480 mg is the sheet's dose. 480 / 36 = 13.3 mg/kg, inside the range. 650 / 36 = 18.1 and 1 000 / 36 = 27.8 mg/kg, above 15. 160 / 36 = 4.4 and 320 / 36 = 8.9 mg/kg, below 10. One defensible key. Options low to high. The twist (package dose by age against weight) is new against the catalogue's KF8 items (pediatric-fever lines 55, 65, 98, 110, 152, 291), which key a bare mg/kg dose or counselling. Tag KF8 is the literal key feature.
- q3 FAIL (section 2), on the explanation only. The key is right and single: ATA 2016 advises a differential white count during febrile illness or pharyngitis in anyone taking an antithyroid drug, and for children stopping the drug and checking the count with fever, mouth sores or pharyngitis. Strep, viral swab and monospot would miss agranulocytosis. Tag KF1 (a host factor sets the septic workup) is acceptable. Infectious-diseases KF3 (host risk factors) would fit equally, so this goes to the physician, not a failure.
- q4 PASS. 0.2 x 10^9/L is below 0.5 x 10^9/L (500/microlitre). Vicente 2017 full text read (PMC5318340): "Intravenous broad-spectrum antibiotics are the mainstay of treatment, initiated soon after blood, urine and other samples are cultured. Hospitalization is usually required ...", with G-CSF in selected patients and mixed evidence. Every claim in the explanation matches. Tag KF3 is honest. No catalogue item keys agranulocytosis.
  - Writer flag, Vicente as a narrative review: acceptable. It is a real, peer-reviewed review that supports every claim, and no pediatric guideline covers the antibiotic step. The key is standard febrile neutropenia care. Physician-level note only.
  - B6 note: the q4 update ("absolute neutrophil count is 0.2 x 10^9/L") implies the q3 key (CBC) in mock mode. q4 cannot work without the count, so it stays and is flagged under B6.

### pediatric-fever-50 (Boy with a cold and green discharge)

- q1 to q3 PASS. Unchanged from the version that passed. Rechecked: the AAP 2013 patterns (persistent beyond 10 days, worsening after improvement, severe onset with 39°C or more and purulent discharge for 3 days in a row) match the explanation. 6 days of symptoms and 2 days of 38.4°C meet none. "Worsening course" is a pattern where the AAP says to prescribe, so the q3 key is single. Choosing Wisely Canada recommendation 2 supports q2.
- 3 questions. See the coordinator note in section 5.

### pediatric-fever-51 (Girl whose legs hurt too much to walk)

- Stem PASS. "Takes no medications" added. The q3 explanation relies on it.
- q1 PASS. Unchanged. Thompson 2006 figures confirmed by the previous review and consistent with the stem (9 hours).
- q2 PASS. SSC children 2026 (SCCM page read): "we recommend measuring blood lactate as part of initial evaluation and management" for probable sepsis or suspected septic shock (strong, very low certainty). The only procalcitonin statement is against routine use to guide de-escalation. The explanation is accurate. Uniqueness: catalogue lactate keys are adult findings or tracking measures (shock lines 455, 511, 554, infectious-diseases line 534). None keys lactate as the test to add in a child. Tag KF1, writer flag: it reads "other factors" broadly, but lactate is part of the septic workup that her risk sets, and KF2 or KF3 fits worse. Acceptable, recorded for the physician.
- q3 PASS. SSC 2026 statements confirmed: a suggestion against IV hydrocortisone once fluid and vasoactive therapy restore stability, stress-dose steroids for suspected or documented adrenal insufficiency, suggestions against vitamin C, thiamine and routine levothyroxine, crystalloids over albumin, no recommendation on bicarbonate. Every distractor reason is true and traces to the stem or updates. Tag shock KF8 is honest (non-fluid therapy only when indicated). No catalogue key keys "nothing added" in restored pediatric septic shock. Hydrocortisone keys elsewhere are for refractory shock or adrenal crisis.
- SAMP field: FAIL, `alsoTopics` (section 2).

### pediatric-fever-52 (Fever and a dark spot during treatment)

- q1 and q2 PASS. Unchanged and passed before.
- q3 PASS. 2023 guideline full text read (PMC10022858). A6b: "Reserve addition of a second anti-Gram-negative agent or a glycopeptide for patients who are clinically unstable, when a resistant infection is suspected ...". B3 also escalates cover in a patient who becomes unstable. BP 74/38 mmHg in a 7-year-old is below 70 + 2 x 7 = 84 mmHg, so he is hypotensive and unstable. Metronidazole (piperacillin-tazobactam already covers anaerobes), clindamycin (no aerobic gram-negative activity), fluconazole (empiric antifungal is for fever lasting 96 hours or more) and acyclovir are correctly rejected.
  - Writer flag, gentamicin as the single key: correct. Of A6b's two choices, only the second anti-gram-negative agent is offered. The other escalation routes (vancomycin, a switch to a carbapenem) are not options. The guideline names no aminoglycoside, but gentamicin is the usual choice and the explanation calls it an example ("such as gentamicin"). Pediatric shock-24 in s50 lists "Add gentamicin as a second gram-negative agent" only as a wrong distractor for an adult with no resistance risk, so this is not a repeat.
  - B6 note: the update's neutrophil count implies the q2 CBC key in mock mode. It is needed to show high-risk neutropenia. Flagged, not failed.

## 4. Uniqueness

Every stem and key decision was checked against the catalogues `pediatric-fever.md`, `tox.md` (the only tox catalogue), `delirium-agitation.md`, `infectious-diseases.md` and `shock.md`, and by grep against current Q500 text in `src/samps/s5*`, `s6*`, `s70` and `src/cases/batch11` to `batch15`. No current key repeats a keyed decision, so no D1 entry is needed. The near-duplicate stem test passes.

## 5. Notes for the coordinator and the physician (not grounds for failure)

1. Question count. Q500_BRIEF says "4 or 5 per SAMP". SAMP_SPEC and the tests allow 3 to 5. Four of the five SAMPs (48, 50, 51, 52) have 3 questions, and the batch has 16 questions, not about 20. The writer says the coordinator allowed 3 where no new decision exists. I could not see that allowance in writing. The coordinator should confirm it.
2. 48 is a pediatric fever SAMP with 2 of its 3 questions tagged to other topics. SAMP_SPEC allows it. The physician may prefer more pediatric fever weight.
3. 48 q2: charcoal beyond 1 hour for anticholinergics varies in practice (see above).
4. 48 stem timeline: symptoms began at 18:00, at least 3 hours after the last chance to ingest at 15:00. Dimenhydrinate symptoms usually begin sooner. Slowed absorption makes this plausible, but the physician may want the drive to end later, for example at 16:30.
5. 48 q3: central anticholinergic delirium can outlast the peripheral signs. The key rests mainly on fever that persists once sweating returns. CT before LP is a judgement and is not offered. The International Encephalitis Consortium's major criterion asks for altered mental status lasting 24 hours or more, and at 15 hours she does not yet meet it. The explanation does not claim she does.
6. Mock-mode cues (B6), all kept because the later question needs the fact: 48 q2 update and q3 (imply q1), 49 q4 update (implies q3), 52 q3 update (implies q2).
7. Broad KF1 tags on 49 q3 and 51 q2, as discussed above.
8. 49 q4 rests on a narrative review (Vicente 2017).

## 6. Sources verified

- SickKids AboutKidsHealth acetaminophen dose sheet: PDF downloaded and read (created and modified in 2024). https://www.aboutkidshealth.ca/globalassets/assets/acetaminophen-and-ibuprofen-dose-recommendations.pdf
- Chyka PA et al. 2005, Clin Toxicol: Europe PMC record and abstract read. https://pubmed.ncbi.nlm.nih.gov/15822758/
- Lehrnbecher T et al. 2023, J Clin Oncol: full text read (A6a, A6b, B3, C4 to C6). https://pubmed.ncbi.nlm.nih.gov/36689694/ (PMC10022858)
- Vicente N et al. 2017, Drugs R D: abstract and full text read. https://pubmed.ncbi.nlm.nih.gov/28105610/ (PMC5318340)
- Weiss SL, Peters MJ et al. SSC children 2026: SCCM page read (lactate, hydrocortisone, vitamin C, thiamine, levothyroxine, albumin, bicarbonate, procalcitonin). https://www.sccm.org/clinical-resources/guidelines/guidelines/surviving-sepsis-campaign-international-guidelines-for-the-management-of-sepsis-and-septic-shock-in
- Venkatesan A et al. 2013, Ross DS et al. 2016, Scharman EJ et al. 2006, Thompson MJ et al. 2006, Wald ER et al. 2013: titles, authors, journals and years confirmed via Europe PMC. Each URL points to the right record. ATA advice on a white count with fever or pharyngitis confirmed through the Guideline Central ATA summary.
- McDonough 2021 and Gałązka 2021: unchanged, confirmed by the previous review.

## 7. House style

Checked by script: no em or en dashes, smart quotes, micro signs, semicolons in text or absolute words in options. Canadian spelling. No personal names in content (the author field is "Preceptor"). Stems 113 to 148 words. Updates 22 to 41 words. Explanations 445 to 732 characters, 3 to 5 sentences.

## Summary

2 of 5 SAMPs pass (pediatric-fever-50, pediatric-fever-52). 15 of 16 questions pass. Three fixes are required, none of them to a key: add `alsoTopics` to pediatric-fever-48 (`tox`, `infectious-diseases`) and to pediatric-fever-51 (`shock`), and reword the pediatric-fever-49 q3 explanation so it does not name methimazole as a given fact. Every fix the previous review required was applied correctly and completely. The writer's five flagged points were each judged acceptable: the 48 q2 mock cue under B6, the charcoal timing, Vicente for 49 q4, gentamicin as the single key under A6b, and the broad KF1 tags. Each is recorded for the physician.
